Related Experiment Video
Updated: Jul 8, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
ACE I/D polymorphism in Indian patients with hypertrophic cardiomyopathy and dilated cardiomyopathy
Taranjit Singh Rai1, Perundurai Subramaniam Dhandapany, Tarunveer Singh Ahluwalia
1Department of Experimental Medicine and Biotechnology, Post Graduate Institute of Medical Education and Research, Chandigarh 160012, India.
Insights
The angiotensin converting enzyme (ACE) D allele is linked to a higher risk of hypertrophic cardiomyopathy (HCM) and dilated cardiomyopathy (DCM). This genetic variant influences disease phenotypes in patients with these heart conditions.
Area of Science:
- Cardiovascular Genetics
- Molecular Cardiology
- Genetic Epidemiology
Background:
- Cardiomyopathies, including hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and restrictive cardiomyopathy (RCM), represent significant cardiovascular diseases.
- The angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism is a potential genetic risk factor for various cardiovascular conditions.
Purpose of the Study:
- To investigate the association between the ACE I/D polymorphism and the risk of developing HCM, DCM, and RCM.
- To explore the influence of ACE I/D genotypes on clinical phenotypes and disease severity in cardiomyopathy patients.
Main Methods:
- Case-control study including 174 cardiomyopathy patients (118 HCM, 51 DCM, 5 RCM) and 164 matched controls.
- ACE I/D genotyping performed using polymerase chain reaction (PCR).
- Statistical analysis adjusted for age, sex, body mass index (BMI), and smoking habit.
Main Results:
- The ACE DD genotype and 'D' allele were significantly more prevalent in cardiomyopathy patients compared to controls, indicating an increased risk (DD: OR 2.11; 'D' allele: OR 1.91).
- Male patients exhibited a higher frequency of cardiomyopathy compared to female patients (P < 0.05).
- In DCM patients, the ID genotype was associated with a significantly reduced left ventricular ejection fraction (LVEF) at enrollment (26.50 +/- 8.04%, P = 0.04).
Conclusions:
- The 'D' allele of the ACE I/D polymorphism is a significant genetic factor associated with an increased risk and specific phenotypes of HCM and DCM.
- ACE I/D polymorphism may play a role in the pathogenesis and clinical presentation of these cardiomyopathies.
Aim:
The study was carried to determine the association of angiotensin converting enzyme (ACE) insertion/deletion (I/D) polymorphism with the risk of hypertrophic cardiomyopathy (HCM), dilated cardiomyopathy (DCM), and restrictive cardiomyopathy (RCM).
Methods And Results:
A total of 174 patients diagnosed with cardiomyopathy (118 with HCM, 51 with DCM, and 5 with RCM) and 164 ethnically, age- and gender-matched controls were included in the study. ACE I/D genotyping was performed by PCR. In total, 25.86% of the patients were in New York Heart Association (NYHA) class III and IV at presentation. A total of 67.24% patients had dyspnea, 56.89% had angina pectoris, and 25.28% of the patients had at least one event of syncope. Frequency of occurrence of the disease was more in male patients compared to female patients (P < 0.05). After adjustment for age, sex, body mass index (BMI), and smoking habit, the prevalence of ACE DD genotype, and ACE 'D' allele was significantly higher in patients as compared to controls and was associated with increased risk (DD: OR 2.11, 95% CI 1.27-3.52, P < 0.05; 'D': OR 1.91, 95% CI 1.08-3.35, P < 0.05). The mean septal thickness was higher for DD and ID genotypes (20.40 +/- 3.73 mm and 21.82 +/- 5.35 mm, respectively) when compared with II genotype (18.63 +/- 6.69 mm) in HCM patients, however, the differences were not significant statistically (P > 0.05). The DCM patients with ID genotype showed significantly decreased left ventricular ejection fraction (LVEF) at enrolment (26.50 +/- 8.04%) (P = 0.04).
Conclusion:
Our results suggest that D allele of ACE I/D polymorphism significantly influences the HCM and DCM phenotypes.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Cardiomyopathy V: Interprofessional Care
Myocarditis I: Introduction

